Seres Therapeutics Inc. (MCRB) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear

Seres Therapeutics Inc.

NASDAQ: MCRB · Real-Time Price · USD
19.36
0.56 (2.98%)
At close: Sep 05, 2025, 3:59 PM
19.32
-0.23%
After-hours: Sep 05, 2025, 05:40 PM EDT

Seres Therapeutics Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
n/a 126.33M 7.13M 144.93M
Cost of Revenue
14.7M 704K 1M 141.89M
Gross Profit
-14.7M 125.62M 6.12M 144.93M
Operating Income
-121.31M -107.98M -246.49M -64.49M
Interest Income
3.97M 7.3M 3.06M 2.87M
Pretax Income
-125.77M -113.72M -250.16M -65.58M
Net Income
136K -113.72M -250.16M -65.58M
Selling & General & Admin
53.18M 87.74M 79.69M 69.26M
Research & Development
64.6M 145.86M 172.92M 141.89M
Other Expenses
-14.43M n/a 1M -1.73M
Operating Expenses
103.35M 233.6M 253.62M 209.42M
Interest Expense
n/a 13.18M 6.02M 2.91M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
121.31M 234.31M 253.62M 209.42M
Income Tax Expense
n/a n/a 3.67M -4.08M
Shares Outstanding (Basic)
155.4M 128M 108.08M 4.59M
Shares Outstanding (Diluted)
7.77M 128M 108.08M 4.59M
EPS (Basic)
0.00 -0.89 -2.31 -14.3
EPS (Diluted)
-18.86 -0.89 -2.31 -14.3
EBITDA
-111.07M -94.31M -237.51M -56.72M
EBIT
-125.77M -100.55M -244.14M -62.67M
Depreciation & Amortization
14.7M 6.24M 6.63M 5.95M